Contributors
Discussions
The last comments for
Signifor® (Pasireotide) is now Commercially Available

kim
Has the Signifor helped you? Have any of the side effects gone away? I'm thinking of starting...
August 07, 2013 01:50:41 Jump to
The last comments for

stella
was diagnosed with Cushing\'s syndrome last week,19th July 2013 and your story resonates with mine. It\'s...
July 25, 2013 01:04:10 Jump to
The last comments for

Nicole
Thanks! Pretty valuable post!
June 26, 2013 03:24:50 Jump to
The last comments for

weight loss
nice stuff
May 05, 2013 17:20:19 Jump to
The last comments for
Predictors of Mortality, CVD Risk in Cushing's Disease ID'd

Katrina
Genuinely when someone doesn\'t know afterward its up to other people that they will help, so here it...
May 02, 2013 21:14:42 Jump to
Comments by IntenseDebate
Categories
- 17a-OH-Progesterone (1)
- 24-hour urine free cortisol (1)
- 24-hour urine test (3)
- abbreviations (1)
- ABC TV (2)
- abstract (5)
- acne (3)
- acromegaly (4)
- ACTH (18)
- activist (1)
- Addison-Biermer disease (2)
- Addison-Schilder syndrome (2)
- Addison's (5)
- Addison's Disease (72)
- Addison’s disease (1)
- Addisonian anemia (1)
- Addisonian crisis (1)
- adenoma (17)
- adrenal (45)
- adrenal cortex (1)
- Adrenal Crisis (33)
- Adrenal Fatigue (8)
- adrenal glands (84)
- Adrenal Insufficiency (58)
- adrenal medulla (1)
- adrenal vein sampling (1)
- adrenal venous sampling (1)
- adrenal-sparing (1)
- adrenalectomy (25)
- adrenaline (1)
- adrenocortical carcinoma (3)
- Adrenoleukodystrophy (1)
- AI (1)
- aldosterone (10)
- aldosteronism (2)
- Alice (2)
- AMRC5 mutation (1)
- androgen (2)
- anniversary (1)
- anxiety (1)
- app (1)
- appendicitis (1)
- April Fools (1)
- arthritis (3)
- autoimmune (1)
- AVIS (1)
- AVS (1)
- award (1)
- awareness (8)
- BclI polymorphism (1)
- benign (3)
- bilateral (2)
- bios (3)
- birthday (2)
- BLA (5)
- blogger (4)
- blogs (10)
- BlogTalkRadio (2)
- blood (2)
- blood pressure (4)
- blood test (2)
- Blue and Yellow (1)
- body image (1)
- bone loss (1)
- books (1)
- brochures (1)
- bruising (2)
- buffalo hump (1)
- Cabergoline (1)
- CAH (6)
- cancer (5)
- Capitol Hill (1)
- carcinoma (1)
- cardiac (1)
- cardiovascular (1)
- Carney Complex (1)
- celiac (3)
- chat (1)
- childhood (1)
- children (2)
- chronic fatigue (1)
- chronic illness (1)
- Chronocort (1)
- chronotherapy (1)
- circadian rhythm (1)
- Cleveland Clinic (2)
- clinical trial (3)
- clinical trials (2)
- comments (1)
- conference (4)
- conference call (1)
- Congenital adrenal hyperplasia (8)
- Congress (1)
- Conn Syndrome (1)
- Conn's Syndrome (3)
- COR-003 (1)
- Corcept (6)
- Corlux (5)
- CORT 108297 (1)
- cortef (3)
- Cortendo AB (1)
- corticosteroids (2)
- corticotropin (3)
- cortisol (14)
- cortisone (6)
- CRH (3)
- Cushie (2)
- Cushie Bookstore (2)
- CushieWiki (6)
- Cushing's (80)
- Cushing's Awareness Challenge (21)
- Cushing's Awareness Day (9)
- Cushing's Disease (15)
- Cushing's Syndrome (5)
- Cushings Help (11)
- CyberKnife (1)
- cyclic (1)
- depression (4)
- dexamethasone (2)
- dexametnosone (1)
- DHEA (3)
- diabetes (14)
- diabetes mellitus (3)
- diagnosis (1)
- disability (1)
- discussion (1)
- doctors (1)
- Donation (1)
- Dr. Adriana Ioachimescu (1)
- Dr. Alfredo Quinones-Hinojosa (1)
- Dr. Amir Hamrahian (2)
- Dr. Barbara Craven (1)
- Dr. Betul A. Hatipoglu (1)
- Dr. Beverly Biller (1)
- Dr. Daniel Kelly (1)
- Dr. David M. Cook (1)
- Dr. Edward Laws (1)
- Dr. Edward Oldfield (1)
- Dr. Harvey Cushing (1)
- Dr. Harvey Williams Cushing (1)
- Dr. James Findling (1)
- Dr. James Lind (1)
- Dr. Lynette Nieman (1)
- Dr. Maria Fleseriu (1)
- Dr. Nelson Oyesiku (1)
- Dr. Roberto Salvatori (2)
- Dr. Shlomo Melmed (1)
- Dr. Theodore Friedman (4)
- drugs (4)
- e-Patient Dave (1)
- Easter (1)
- ectopic (2)
- electrocardiogram (1)
- emergency (1)
- emergency room (1)
- endocrinologist (7)
- endoscopic (2)
- English (1)
- enogenous (1)
- epinephrine (1)
- ER (1)
- exercise (1)
- exophthalmos (1)
- familial (2)
- FAQ (2)
- fatigue (4)
- FDA (4)
- fibromyalgia (1)
- FIPA (1)
- forums (3)
- G-allele (1)
- ganglioneuroma (1)
- genetic (1)
- gland (1)
- Global Genes (1)
- glossary (1)
- glucocorticoid (1)
- glucocorticoids (5)
- glucocortoid (1)
- grand rounds (1)
- Graves' (1)
- Graves' Disease (1)
- Growth Hormone (4)
- haemochromatosis (2)
- Health Activist (1)
- Health Activist Hero award (1)
- Help Wanted (1)
- Helpful Hints (2)
- hemangioma (1)
- hemodialysis (1)
- hGH (2)
- hirsuitism (5)
- holiday (4)
- hormone (1)
- hormones (1)
- HPA axis (4)
- hydrocortisone (3)
- hyperaldosteronism (1)
- hypercortisolism (6)
- hyperkalemia (1)
- hyperplasia (1)
- hyperprolactinemia (1)
- hypertension (2)
- hyperthryoidism (1)
- hypopituitarism (1)
- hypothalamus (1)
- In Memory (3)
- incidentaloma (3)
- infertility (2)
- injection (1)
- insulin (2)
- Insulin Resistance (5)
- Insulin Tolerance Test (1)
- Interviews (7)
- iPad (1)
- iPhone (1)
- IPSS (4)
- Jane Austen (3)
- JFK (7)
- John Kennedy (8)
- Johns Hopkins (4)
- ketoconazole (6)
- kidney (2)
- kidney cancer (1)
- Korlym (11)
- laparoscopic (10)
- levothyroxine (1)
- libido (1)
- Lifetime TV (1)
- liver (1)
- Magic Foundation (1)
- map (1)
- Mary O'Connor (1)
- MaryO (7)
- Mayo Clinic (1)
- media (1)
- Medic Alert ID (1)
- Medical History (4)
- meds (1)
- meeting (2)
- MEN1 (2)
- MEN4 (1)
- message boards (4)
- metyrapone (1)
- midline incision (1)
- Mifepristone (5)
- mitotane (1)
- moon face (1)
- mortality (1)
- MRI (6)
- myelolipoma (1)
- Mystery Diagnosis (1)
- National Women's Health (1)
- Nelson's (1)
- Nelson's Syndrome (1)
- neurosteroids (1)
- neurosurgeon (1)
- News (1)
- news items (2)
- NIH (11)
- noradrenaline (1)
- noripinephrine (1)
- NormoCort (1)
- obese (1)
- obesity (7)
- ophthalmologist (1)
- Oprah (1)
- orphan disease (1)
- osteoporosis (3)
- Pasireotide (3)
- PCOS (3)
- perioperative (1)
- pernicious anemia (2)
- PharmaForm (1)
- pheochromocytoma (13)
- pituitary (52)
- Plenadren® (1)
- PMS (1)
- Podcast (7)
- potassium (3)
- Power Surge (3)
- PPNAD (1)
- prednisone (1)
- pregnancy (2)
- prevention (1)
- primary care (1)
- prizes (1)
- progesterone (1)
- prolactinoma (4)
- Psalm 116 (1)
- pseudocyst (1)
- psoriasis (1)
- quality of life (2)
- R-roscovitine (1)
- radiation (2)
- Rare Disease Congressional Caucus (1)
- Rare Disease Day (1)
- Rare Diseases (4)
- recurrence (2)
- renal artery (1)
- renal cell carcinoma (1)
- resolutions (1)
- retroperitoneal (1)
- ribbons (2)
- Robin (1)
- RSS feed (1)
- salivary (1)
- salivary cortisol (1)
- SEISMIC trial (1)
- Signifor (1)
- SILS (1)
- Sjogren's (1)
- sleep disturbance (1)
- Solu-Cortef (3)
- Spanish (1)
- Spironolactone (1)
- stereotactic (1)
- steroid (2)
- steroids (2)
- straie (4)
- stress (4)
- stretch marks (4)
- stroke (1)
- support (4)
- surgery (25)
- survey (1)
- symptoms (6)
- television (1)
- teriparatide (1)
- testing (4)
- Thankfulness (1)
- Thanksgiving (2)
- The Balancing Act (1)
- The Coffee Klatch (1)
- Thomas Addison (6)
- thyroid (12)
- topical steroid use (1)
- transsphenoidal (8)
- treatment (3)
- TSH (1)
- tumor (13)
- TV (1)
- Twitter (1)
- UFC (2)
- unilateral adrenalectomy (2)
- upgrade (1)
- video (10)
- Vitamin B12 deficiency (1)
- WEGO (1)
- weight (10)
- Wiki (1)
- X-ray (1)
- zebra (1)
- zebrafish (1)
Saturday, March 19, 2016
Dutch adults with primary adrenal insufficiency reported abnormal or severe fatigue, reduced physical activity and significantly reduced quality of life vs. healthy controls, according to recent survey results.
In a cross-sectional study, Eline S. van der Valk, MD, of Amphia Hospital in Breda, the Netherlands, and colleagues also found that patients with Addison’s disease reported physical activity levels that were significantly lower than those reported by other Dutch chronically ill patients.
“The clinical relevance of the impaired [quality of life] and increased fatigue found in our study is supported by the size of the differences in scores and the restriction in physical activity in patients with [Addison’s disease], an important activity in daily life,” the researchers wrote. “Physical inactivity could be very detrimental in [Addison’s disease] because the prevalence of other cardiovascular risk factors is already increased, and it has been demonstrated that patients with [Addison’s disease] have an up to twofold increased mortality rate from [CVDs].”
Researchers analyzed survey data from 328 Dutch adults with Addison’s disease on stable glucocorticoid replacement therapy with hydrocortisone or cortisone acetate (mean age, 53 years; 223 women; mean duration of disease after diagnosis, 15.6 years). Participants attended outpatient clinics at University Medical Center Utrecht and Radboud University Nijmegen Medical Centre, or were members of the Dutch Association of Addison and Cushing Patients. They completed general and health-related quality of life (Short Form 36; Checklist Individual Strength) and physical activity questionnaires. Scores were compared with a random sample of 1,718 adults who completed a Dutch National Health Survey (controls).
Within the cohort, 53% of participants had isolated Addison’s disease; 74.1% received hydrocortisone therapy; 25.9% received cortisone acetate therapy; 87.2% received fludrocortisone therapy; and 23.2% received dehydroepiandrosterone replacement therapy.
Researchers found that 45.7% of participants with Addison’s disease met the standard of physical activity (Dutch standard of healthy physical exercise, defined as moderately intensive physical exercise for 30 minutes daily 5 days per week; “Fitnorm,” defined as 20 minutes of intensive physical exercise at least 3 days per week) vs. 67.8% of controls (P < .01). Researchers found 61% of participants with Addison’s disease reported abnormal fatigue, and 43% reported severe fatigue. Mean fatigue scores were significantly higher vs. controls (mean difference, 32.6; 95% CI, 24-41).
In both men and women with Addison’s disease, researchers found that quality of life scores in all component summaries were significantly decreased compared with controls, particularly in participants aged 65 years and younger. – by Regina Schaffer
Disclosure: The researchers report no relevant financial disclosures.
Subscribe to:
Posts (Atom)